SCHEMBL24724947

SCHEMBL24724947

C/C=N\N(c1ccccn1)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38
ALDH1A1 P00352 3/20 0.36
CHRM2 P08172 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
DRD1 P21728 1/20 0.33
SLC6A2 P23975 1/20 0.33
HTR2A P28223 1/20 0.33
SLC6A4 P31645 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33
OPRK1 P41145 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33
USP2 O75604 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24724667 0.77 CYP2D6 (0.46) CYP2D6CYP2C19ALDH1A1CHRM2ADRA2A
SCHEMBL1225311 0.75 CYP2D6 (0.47) CYP2D6CYP2C19TAAR1ALDH1A1CHRM2
SCHEMBL13338372 0.71 CYP2D6 (0.47) CYP2D6CYP2C19TAAR1ALDH1A1CHRM2
SCHEMBL15785637 0.71 CYP2D6 (0.41) CYP2D6CYP2C19ALDH1A1CHRM2ADRA2A
SCHEMBL22786989 0.70 CYP2D6 (0.40) CYP2D6CYP2C19TAAR1ALDH1A1CHRM2
SCHEMBL85721 0.70 CYP2D6 (0.55) CYP2D6CYP2C19TAAR1ALDH1A1CHRM2
SCHEMBL15785686 0.69 CYP2D6 (0.39) CYP2D6CYP2C19ALDH1A1CHRM2ADRA2A
SCHEMBL13180333 0.66 TAAR1 (0.55) CYP2D6CYP2C19TAAR1ALDH1A1CHRM2
SCHEMBL13145782 0.66 TAAR1 (0.48) CYP2D6CYP2C19TAAR1ALDH1A1CHRM2
SCHEMBL13338416 0.66 ALDH1A1 (0.46) CYP2D6CYP2C19TAAR1ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023028338-A2 MANNOSE 6-PHOSPHATE OR ASGPR RECEPTOR BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS AVILAR THERAPEUTICS, INC. (US) 2023-03-02 WO disclosed
WO-2022235699-A2 POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS AVILAR THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed
US-9610368-B2 Radiolabelled glutaminyl cyclase (QC) inhibitors and uses of same PROBIODRUG AG (DE) 2017-04-04 US disclosed